Different Erythromycin Resistance Mechanisms in Group C and Group G Streptococci
- 1 June 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (6), 1493-1494
- https://doi.org/10.1128/aac.42.6.1493
Abstract
Different mechanisms of erythromycin resistance predominate in group C and G streptococcus (GCS and GGS, respectively) isolates collected from 1992 to 1995 in Finland. Of the 21 erythromycin-resistant GCS and 32 erythromycin-resistant GGS isolates, 95% had the mefA or mefE drug efflux gene and 94% had the ermTR methylase gene, respectively.Keywords
This publication has 27 references indexed in Scilit:
- mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1997
- Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenesMolecular Microbiology, 1996
- Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in FinlandJournal of Antimicrobial Chemotherapy, 1993
- Resistance to Erythromycin in Group A StreptococciNew England Journal of Medicine, 1992
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991
- Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringensAntimicrobial Agents and Chemotherapy, 1989
- Infections Due to Lancefield Group C StreptococciMedicine, 1989
- Erythromycin-resistant beta-haemolytic streptococci in North YorkshireJournal of Infection, 1986
- Infections Due to Lancefield Group G StreptococciMedicine, 1985
- Transposition of Tn554 does not generate a target duplicationNature, 1984